Back to top

Guggenheim Raises Price Target for RYTM to $120, Maintains Buy Rating | RYTM Stock News

Guggenheim Raises Price Target for RYTM to $120, Maintains Buy Rating | RYTM Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Rhythm Pharmaceuticals, Inc. (RYTM)